What does this research mean for the field?

Surface-Enhanced Raman Scattering (SERS) technology, particularly when integrated with artificial intelligence and multimodal approaches, offers significant potential for advancing precision biomedicine in tumor biomarker profiling, bioimaging, diagnostics, and therapy. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to investigate the advancements of SERS technology in tumor diagnostics and treatment.

January 1, 2026Theranostics5 citationsOpen Access

View Full Paper

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

XCXuelin Chen TLTenglong Liu WCWeiyuan Chen

Key Points

This research aims to investigate the advancements of SERS technology in tumor diagnostics and treatment.
Evaluated AI-assisted spectral analysis for tumor diagnostics.
Reviewed multimodal integration and standardized detection protocols.
Discussed large-scale clinical applications of SERS technology.
SERS technology enhances tumor biomarker profiling.
AI-assisted diagnostics show improved precision in bioimaging.
Integration of SERS in clinical settings suggests potential for point-of-care applications.

Abstract

diagnosis; (2) bioimaging; (3) tumor treatment; (4) Artificial intelligence-assisted tumor diagnosis and treatment. Finally, we made the forward look for SERS technology in biomedicine, such as multimodal integration, standardized detection protocols, AI-assisted spectral analysis for point-of-care diagnostics, and large-scale clinical applications.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

Key Points

Abstract

Cite This Study